New cancer drug duo enters human testing
NCT ID NCT07466160
Summary
This study is testing a new combination of two experimental drugs, called 7MW3711 and JS207, for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will give the drugs together, sometimes adding chemotherapy, to see if they are safe and if they can help control the cancer. The trial will enroll about 280 participants to find the right dose and get early signs of whether the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200043, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.